Td Asset Management Inc Athira Pharma, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$10.24 - $20.87 $459,038 - $935,560
-44,828 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$16.48 - $34.3 $77,076 - $160,421
-4,677 Reduced 9.45%
44,828 $1.54 Million
Q3 2020

Nov 10, 2020
BUY
$16.02 - $18.46 $793,070 - $913,862
49,505 New
49,505 $914,000

Others Institutions Holding ATHA

# of Institutions
66
Shares Held
16.9M
Call Options Held
112K
Put Options Held
68K
View Full List

About Athira Pharma, Inc.

ATHA Quotes by TradingView
  • Ticker ATHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,817,700
  • Market Cap $24.2M
  • Description
  • Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...
More about ATHA
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email